ZAG BIO
Live / Allowed — Fifth extension granted (statement of use) (as of 14 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97686797
- Mark type
- Word mark
- Filed
- 21 Nov 2022
- Published for opposition
- 02 Jan 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of anti-drug immune responses; pharmaceutical preparations for the prevention of anti-drug immune responses; pharmaceutical preparations to inhibit rejection of transplanted organs and tissues; pharmaceutical preparations for the treatment of graft versus host disease
- Class 042 — Scientific and technological services: Pharmaceutical research services; pharmaceutical research and development; pharmaceutical drug development services; medical research; biomedical research services; medical and scientific research, namely, conducting clinical trials for others
Owner
- Zag Bio, Inc., Cambridge, MA, US
- Zag Bio, Inc., Cambridge, MA, US
Prosecution history
- 15 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2026 — SOU EXTENSION 5 GRANTED
- 03 Aug 2026 — SOU EXTENSION 5 FILED
- 14 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 4 GRANTED
- 24 Feb 2026 — SOU EXTENSION 4 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 3 GRANTED
- 12 Aug 2025 — SOU EXTENSION 3 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2025 — SOU EXTENSION 2 GRANTED